Teleflex Incorporated  

(Public, NYSE:TFX)   Watch this stock  
Find more results for TFX
194.88
-0.25 (-0.13%)
After Hours: 194.88 0.00 (0.00%)
Mar 28, 5:00PM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range 192.70 - 195.67
52 week 136.53 - 198.89
Open 194.00
Vol / Avg. 339,848.00/270,617.00
Mkt cap 8.76B
P/E 39.09
Div/yield 0.34/0.70
EPS 4.98
Shares 44.91M
Beta 1.03
Inst. own 96%
Feb 23, 2017
Q4 2016 Teleflex Inc Earnings Release (Estimated)
Jan 10, 2017
Teleflex Inc at JPMorgan Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 11.85% 12.72%
Operating margin 13.04% 16.07%
EBITD margin - 26.35%
Return on average assets 6.19% 6.12%
Return on average equity 11.33% 11.43%
Employees 12,600 -
CDP Score - -

Address

550 E Swedesford Rd Ste 400
WAYNE, PA 19087-1601
United States - Map
+1-610-2256800 (Phone)
+1-610-9485101 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM). The Company's products include oxygen therapy products, aerosol therapy products, spirometry products, and ventilation management products, which are offered under Hudson RCI brand. As of December 31, 2016, it manufactured its products at approximately 30 manufacturing sites, with manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States. Its all others businesses include single-use respiratory, urology and cardiac care products, as well as capital equipment.

Officers and directors

Benson F. Smith Non-Executive Chairman of the Board
Age: 69
Bio & Compensation  - Reuters
Liam J. Kelly President, Chief Executive Officer
Age: 50
Bio & Compensation  - Reuters
Thomas E. Powell Chief Financial Officer, Executive Vice President
Age: 55
Bio & Compensation  - Reuters
Thomas Anthony Kennedy Senior Vice President - Global Operations
Age: 54
Bio & Compensation  - Reuters
James J. Leyden Vice President, General Counsel, Secretary
Age: 50
Bio & Compensation  - Reuters
Karen T. Boylan Vice President - Global RA/QA
Age: 45
Bio & Compensation  - Reuters
Cameron P. Hicks Vice President - Global Human Resources
Age: 52
Bio & Compensation  - Reuters
Patricia C. Barron Lead Independent Director
Age: 74
Bio & Compensation  - Reuters
Gretchen R. Haggerty Director
Age: 60
Bio & Compensation  - Reuters
George Babich Jr. Independent Director
Age: 63
Bio & Compensation  - Reuters